Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer
This study has been completed.
First Received: June 20, 2003   Last Updated: August 18, 2009   History of Changes
Sponsor: ImClone LLC
Collaborator: Bristol-Myers Squibb
Information provided by: ImClone LLC
ClinicalTrials.gov Identifier: NCT00063141
  Purpose

The purpose of this study is to determine whether overall survival is prolonged in subjects with metastatic, epidermal growth factor receptor (EGFR)-positive colorectal cancer treated with cetuximab in combination with irinotecan compared with irinotecan alone as second-line therapy following treatment with a fluoropyrimidine and oxaliplatin based, non-irinotecan-containing regimen.


Condition Intervention Phase
Colorectal Cancer
Drug: cetuximab
Drug: Irinotecan
Phase III

Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title: Revised Protocol 07 to Protocol CA225006 - A Phase III Randomized, Open-Label, Multicenter Study of Irinotecan and Cetuximab vs. Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Carcinoma

Resource links provided by NLM:


Further study details as provided by ImClone LLC:

Primary Outcome Measures:
  • Overall Survival [ Time Frame: Every 3 months after subject off-treatment ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Progression Free Survival [ Time Frame: Q6 Weeks ] [ Designated as safety issue: No ]
  • Response [ Time Frame: Q6 Weeks ] [ Designated as safety issue: No ]
  • Duration of Response [ Time Frame: Q6 Weeks ] [ Designated as safety issue: No ]
  • Time to Response [ Time Frame: Q6 Weeks ] [ Designated as safety issue: No ]
  • Disease Control Rate [ Time Frame: Q6 Weeks ] [ Designated as safety issue: No ]
  • Safety [ Time Frame: Q3 Weeks ] [ Designated as safety issue: Yes ]
  • Quality of Life [ Time Frame: Q6 Weeks ] [ Designated as safety issue: No ]
  • Health Economics [ Time Frame: Q3 Weeks ] [ Designated as safety issue: No ]

Enrollment: 1302
Study Start Date: April 2003
Study Completion Date: October 2007
Primary Completion Date: June 2006 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Arm A: Experimental Drug: cetuximab
Vial, IV, 400 mg/m² week 1 then 250 mg/m², weekly, until PD/Toxicity/Pt-PI Decision
Drug: Irinotecan
Vial, IV, 350 mg/m², Q 3 Weeks, Until PD/Toxicity/Pt-PI Decision
Arm B: Active Comparator Drug: Irinotecan
Vial, IV, 350 mg/m², Q 3 Weeks, Until PD/Toxicity/Pt-PI Decision

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Histologically documented colorectal cancer which is EGFR-positive by immunohistochemistry [IHC] (may be based on archival samples) and is metastatic.
  • Prior oxaliplatin administered for the first-line treatment of metastatic colorectal cancer.
  • Prior fluoropyrimidine-containing regimen (5-fluorouracil [5-FU], capecitabine, or uracil/tegafur [UFT]), for the first-line treatment of metastatic disease.

Exclusion Criteria:

  • A serious uncontrolled medical disorder that, in the opinion of the Investigator, would impair the ability of the subject to receive protocol therapy
  • Unresolved diarrhea, bowel obstruction, or history of inflammatory bowel disease
  • Known or documented brain metastases
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00063141

  Hide Study Locations
Locations
United States, Arizona
ACRC/Arizona Clinical Research Center
Tucson, Arizona, United States, 85712
United States, Arkansas
Arkansas Cancer Clinic, P.A.
Pine Bluff, Arkansas, United States, 71603
United States, California
California Cancer Care
Greenbrae, California, United States, 95904
Compassionate Cancer Care Medical
Corona, California, United States, 92708
South Valley Medical Plaza
Gilroy, California, United States, 95020
Nerses Tchekmedyian, MD
Long Beach, California, United States, 90813
Tower Hematology/Oncology
Beverly Hills, California, United States, 90211
Cancer and Blood Institute of the Desert
Rancho Mirage, California, United States, 92270
Comprehensive Blood and Cancer Center
Bakersfield, California, United States, 93309
Kaiser Permanente Medical Center
Vallejo, California, United States, 94589
Oncology Care Medical Associates
Montebello, California, United States, 90640
Metropolitan Hematology/Oncology Medical Center
Los Angeles, California, United States, 90057
Comprehensive Cancer Center
Palm Springs, California, United States, 92262
USC/Norris Comprehensive Cancer Center
Los Angeles, California, United States, 90033
Alta Bates Comprehensive Cancer Center
Berkeley, California, United States
Southern California Permanente Medical Group
San Diego, California, United States
Stockton Hem/Onc Med Group
Stockton, California, United States, 95204
Medical Oncology Care Associates
Orange, California, United States, 92868
United States, Colorado
Rocky Mountain Cancer Center-Midtown
Denver, Colorado, United States, 80218
Rocky Mountain Cancer Center - Aurora
Aurora, Colorado, United States, 80012
United States, Connecticut
Hematology Oncology, P.C.
Stamford, Connecticut, United States, 06902
Yale University School of Medicine
New Haven, Connecticut, United States, 06520
Eastern CT Hematology Oncology Associates
Norwich, Connecticut, United States, 06360
Oncology & Hematology Associates, PC
New London, Connecticut, United States, 06320
United States, Florida
Integrated Community Oncology Network
Jacksonville, Florida, United States, 32207
Hematology-Oncology Associates
Port St. Lucie, Florida, United States, 34952
Watson Clinic, LLP Center for Cancer Care & Research
Lakeland, Florida, United States, 33805
University of Miami School of Medicine
Miami, Florida, United States, 33136
Mayo Clinic Jacksonville
Jacksonville, Florida, United States, 32224
Florida Cancer Specialist
Fort Myers, Florida, United States, 33901
Florida Cancer Specialists
Fort Myers, Florida, United States, 33990
Nature Coast Clinical Research, LLC
Inverness, Florida, United States, 34452
Pasco Hernando Oncology
New Port Richey, Florida, United States, 34652
University of Florida Health Science Center/Jacksonville
Jacksonville, Florida, United States, 32209
MD Anderson Cancer Center Orlando
Orlando, Florida, United States, 32806
Lakeland Regional Cancer Center
Lakeland, Florida, United States, 33805
United States, Georgia
Peachtree Hematology and Oncology
Atlanta, Georgia, United States, 30309
Central Georgia Hematology and Oncology
Macon, Georgia, United States, 31201
Georgia Cancer Specialist
Tucker, Georgia, United States, 30342
Summit Care Center
Savannah, Georgia, United States, 31405
The Medical Center
Columbus, Georgia, United States, 31902-0951
Winship Cancer Institute
Atlanta, Georgia, United States, 30322
United States, Hawaii
Hawaii Pacific Health Research Institute
Honolulu, Hawaii, United States
United States, Illinois
Edward Cancer Center
Naperville, Illinois, United States, 60540
United States, Indiana
Michiana Hematology Oncology, P.C.
South Bend, Indiana, United States, 46601
United States, Kansas
University of Kansas Medical Center
Kansas City, Kansas, United States, 66160
Kansas City Cancer Centers
Overland Park, Kansas, United States, 66214
United States, Kentucky
University of Kentucky
Lexington, Kentucky, United States, 40536-0098
Kentuckiana Cancer Institute, PLLC
Louisville, Kentucky, United States, 40202
Commonwealth Cancer Center of Richmond
Richmond, Kentucky, United States
United States, Louisiana
Hematology/Oncology Clinic
Baton Rouge, Louisiana, United States, 70808
Oncology and Hematology
Metairie, Louisiana, United States, 70006
LSU Health Sciences Center
Shreveport, Louisiana, United States, 71103
Louisiana Oncology Associates
Lafayette, Louisiana, United States, 70506
United States, Maryland
Greater Baltimore Medical Center
Baltimore, Maryland, United States, 21204
Frederick Memorial Hospital Regional
Frederick, Maryland, United States, 21701
United States, Massachusetts
Caritas St. Elizabeth's Medical Center
Boston, Massachusetts, United States
United States, Michigan
St. Joseph Mercy Hospital Cancer Care Center
Ann Arbor, Michigan, United States, 48106
Providence Cancer Center
Southfield, Michigan, United States, 48075
Karmanos Cancer Research
Detroit, Michigan, United States, 48201
United States, Minnesota
Metro Minnesota CCOP
St. Louis Park, Minnesota, United States, 55426
Virginia Piper Cancer Institute
Minneapolis, Minnesota, United States, 55407-3799
Hubert H. Humphrey Cancer Center
Robbinsdale, Minnesota, United States, 55422
United States, Mississippi
Jackson Oncology Associates
Jackson, Mississippi, United States, 39202
United States, Missouri
Kansas City Cancer Centers, Llc.
Kansas City, Missouri, United States, 64111
Washington University Medical Center
St. Louis, Missouri, United States, 63110
Bond Clinic, Inc.
Rolla, Missouri, United States, 65401
United States, New Jersey
CINJ at Cooper University Hospital
Voorhees, New Jersey, United States, 08084
The Cancer Inst of NJ at Hamilton
Trenton, New Jersey, United States, 08690
United States, New York
New York Oncology Hematology
Rexford, New York, United States, 12148
New York Medical College/Westchester
Valhalla, New York, United States, 10595
New York Oncology Hematology Associates
Albany, New York, United States, 12208
Our Lady of Mercy Hospital
Bronx, New York, United States, 10466
Suny @ Stony Brook
Stony Brook, New York, United States, 11794
New York University Clinical Cancer Institute
New York, New York, United States, 10016
New York Oncology Hematology
Latham, New York, United States, 12110
Winthrop University Hospital
Mineola, New York, United States, 11501
North Shore Hematology Oncology
East Setauket, New York, United States, 11733
United States, North Carolina
Raleigh Hematology Oncology Associates, Wake Practice
Raleigh, North Carolina, United States, 27609
Piedmont Hematology Oncology Associates
Winston-Salem, North Carolina, United States, 27103
Emerywood Hematology and Oncology
High Point, North Carolina, United States
Physician's East PA
Greenville, North Carolina, United States, 27834
Duke University Medical Center
Durham, North Carolina, United States, 27710
East Carolina University School of Medicine
Greenville, North Carolina, United States
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States, 27157
United States, North Dakota
Mid Dakota Clinic
Bismarck, North Dakota, United States, 58501
United States, Ohio
Hematology Oncology Consultants
Columbus, Ohio, United States, 43235
Hematology Oncology Consultants Inc
Newark, Ohio, United States, 43055
Medical Oncology Hematology Associates
Dayton, Ohio, United States, 45459
University of Cincinnati Barrett Cancer Center
Cincinnati, Ohio, United States, 45267
Case Western Reserve University
Cleveland, Ohio, United States, 44106
United States, Oklahoma
Cancer Specialists of Oklahoma
Oklahoma City, Oklahoma, United States
United States, Pennsylvania
Hershey Medical Center
Hershey, Pennsylvania, United States, 17033
Pennsylvania Oncology/Hematology Associates
Philadelphia, Pennsylvania, United States, 19106
Albert Einstein Cancer Center
Philadelphia, Pennsylvania, United States, 19141-3098
Jefferson Medical College
Philadelphia, Pennsylvania, United States, 19107
Hillman Cancer Center
Pittsburgh, Pennsylvania, United States, 15232
United States, South Carolina
Cancer Centers of the Carolinas
Greenville, South Carolina, United States, 29615
United States, Tennessee
Thompson Cancer Survival Center
Knoxville, Tennessee, United States, 37916
The West Clinic, P.C.
Memphis, Tennessee, United States, 38120
The Sarah Cannon Cancer Center
Nashville, Tennessee, United States, 37203
United States, Texas
Center for Oncology Research and Treatment
Dallas, Texas, United States, 75230
Lone Star Oncology Consultants
Austin, Texas, United States, 78759
Scott & White Memorial Hospital
Temple, Texas, United States, 76508
North Texas Regional Cancer Center
Plano, Texas, United States, 75075
Texas Cancer Center at Medical City
Dallas, Texas, United States, 75230
Department of Gastrointestinal Medical Oncology
Houston, Texas, United States, 77030
United States, Utah
Northern Utah Associates
Ogden, Utah, United States, 84403
United States, Virginia
Danville Hematology and Oncology Inc.
Danville, Virginia, United States, 24541
Arlington-Fairfax Hematology Oncology
Arlington, Virginia, United States, 22205
Virginia Oncology Associates
Newport News, Virginia, United States, 23606
Virginia Cancer Institute
Richmond, Virginia, United States, 23230
United States, Washington
Cancer Care Northwest
Spokane, Washington, United States, 99218
St. Mary Medical Center St. Mary Regional Cancer Center
Walla Walla, Washington, United States, 99362
Swedish Medical Center
Seattle, Washington, United States, 98104
Medical Oncology Associates
Spokane, Washington, United States, 99204
United States, Wisconsin
Froedtert Memorial Lutheran Hospital/Clinic
Milwaukee, Wisconsin, United States, 53226
University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States, 53792
Green Bay Oncology, Ltd/St. Vincent Hospital
Green Bay, Wisconsin, United States, 54301
Australia
Wilhelminenspital Der Stadt Wien
Wien, Australia
Australia, Australian Capital Territory
Prince of Wales Hospital
Sydney, Australian Capital Territory, Australia
Mount Medical Centre, Perth Oncology
Perth, Australian Capital Territory, Australia
Australia, New South Wales
Southern Medical Day Care, Med Onc
Wollongong, New South Wales, Australia
Sydney Cancer Centre
Sydney, New South Wales, Australia
St. Vincent's Hospital
Sydney, New South Wales, Australia
Australia, Queensland
Mater Adult Hospital
South Brisbane, Queensland, Australia
Australia, South Australia
The Queen Elizabeth Hospital
Adelaide, South Australia, Australia
Flinders Medical Centre
Adelaide, South Australia, Australia
Austria
Universitatsklinik Fur Innere Medizin I
Wein, Austria
Krankenhaus Der Stadt Wien Rudolfstiftung
Wien, Austria
Krankenh aus Der Stadt Wien Lainz
Wein, Austria
Donauspital Im Smz-Ost Der Stadt Wien
Wien, Austria
Medizinische Universitatsklinik
Graz, Austria
St. Johanns Spital-Landeskrankenhaus
Salzburg, Austria
Belgium
Centre Hospitalier Notre-Dame-Reine Fabiola
Charleroi, Belgium
Czech Republic
Fakultini Nemocnice V Motole
Praha 5, Czech Republic
Clinical Trials Unit
Brno, Czech Republic
Fakultni Nemocnice Olomouc
Olomouc, Czech Republic
Finland
Eira Hospital
Helsinki, Finland
France
Centre Rene Gauducheau, Site Hospitalier Nord
Saint Herblain, France
Hopital Jean Minjoz
Saint Herblain, France
Institut Paoli-Calmettes
Marseille, France
Centre Antoine Lacassagne
Nice, France
Institut Sainte Catherine
Avignon, France
Germany
Robert-Bosch-Krankenhaus Stuttgart
Stuttgart, Germany
Krankenhaus Munchen-Bogenhausen
Munchen, Germany
Westpfalz-Klinkum Gmbh
Kaiserslautern, Germany
Medizinische Klinik Mitte
Dortmund, Germany
Fakultaet F.Klin.Med. Mannheim
Mannheim, Germany
Stadtisches Klinikum Magdeburg Krankenhaus Alstadt
Magdeburg, Germany
Gemeinschaftspraxis Hamatologie/Onkologie
Magdeburg, Germany
Klinikum Der Hansestadt Stralsund Gmbh
Stralsund, Germany
Caritasklinik St. Theresia/Saarbrucken
Saarbrucken, Germany
Universitatsklinik Mainz
Mainz, Germany
Stadtisches Klinikum Dessau
Dessau, Germany
Univ Munchen-Grosshadern
Munchen, Germany
Klinikum Kassel
Kassel, Germany
Universitatsklinikum Essen
Essen, Germany
Klinikum Augsburg
Augsburg, Germany
Facharzt Fur Innere Medizin
Muchnhen, Germany
Weissenbaurger Strasse 28
Aschaffenburg, Germany
Klinikum Der Univ. Regensburg
Regensburg, Germany
Marienkrankenhaus Hamburg
Hamburg, Germany
Innovation Onkologie Res and Consulting-Gmbh (Iorc)
Hanburg, Germany
Hong Kong
Prince of Wales Hospital
Hong Kong, Hong Kong
Italy
Az Osp S Martino Genova Univ Conv
Genova, Italy
Universita Cattolica
Roma, Italy
Universita Napoli Federico Ii
Napoli, Italy
Azienda Ospedaliera S. Maria Nuova
Reggio Emilia, Italy
Clinica Di Oncologica Medica, Ospedale Regionale Torrette
Ancona, Italy
Universita Di Napoli
Napoli, Italy
Instituto Regina Elena
Rome, Italy
Azienda Ospedaliera Policlinico De Modena
Modena, Italy
Azienda Ospedaliera Careggi
Firenze, Italy
Azienda San Locale N6 Presido Ospedaliero Di Livomo
Livomo, Italy
Azienda Ospedaliera Ospedali Riuniti Bergamo
Bergamo, Italy
Ospedale Niguarda CaGranda
Milano, Italy
Istituto Per La Ricerca E La Cura Del Cancro
Candiolo, Italy
Pol Monteluce Az Ops Di Perugia
Perugia, Italy
Italy, Milano
Divisione Di Oncologia Medica Via Manzoni, 56
Rozzano, Milano, Italy
Netherlands
Albert Schweitzer Hospital, Locatie Dordwijk
Dordrecht, Netherlands
Geire Ziekenhuis Locatie Lukas
Apeldorn, Netherlands
Norway
Ullevals Hospital
Oslo, Norway
Norway, Oslo
Det Norske Radiumhospitalet Hf
Montebello, Oslo, Norway
Portugal
Institutio Portugues De Oncologia
Porto, Portugal
Slovakia
National Cancer Institute
Bratislava, Slovakia
Onkologicky Ustav Sv. Alzbety, S.R.O.
Bratislava, Slovakia
Sweden
University Hospital
Lund, Sweden
Karolinska Hospital
Stockholm, Sweden
Switzerland
Inselpital
Bern, Switzerland
Stadtspital Triemli
Zurich, Switzerland
Universitatsspital Zurich
Zurich, Switzerland
Kantonsspital
Zurich, Switzerland
Kantonsspital Liestal
Liestal, Switzerland
Birmensdorferstrasse 497
Zurich, Switzerland
United Kingdom, Aberdeenshire
Aberdeen Royal Infirmary
Foresterhill, Aberdeenshire, United Kingdom
United Kingdom, Avon
Princess Royal Hospital
Hull, Avon, United Kingdom
United Kingdom, Central
Beatson Oncology Ctr Glasgow
Glasgow, Central, United Kingdom
United Kingdom, Dorset
Poole General Hospital
Poole, Dorset, United Kingdom
United Kingdom, Greater London
Guys Hospital
London, Greater London, United Kingdom
United Kingdom, Hampshire
The Royal Bournemouth Hospital Trust
Bournemouth, Hampshire, United Kingdom
United Kingdom, Surrey
Royal Marsden Hospital
Sutton, Surrey, United Kingdom
Royal Surrey Country Hospital
Guildford, Surrey, United Kingdom
Sponsors and Collaborators
ImClone LLC
Bristol-Myers Squibb
Investigators
Study Director: ImClone Systems ImClone LLC
  More Information

Additional Information:
No publications provided

Responsible Party: ImClone Systems ( Eric Rowinsky, Chief Medical Officer )
Study ID Numbers: CA225-006
Study First Received: June 20, 2003
Last Updated: August 18, 2009
ClinicalTrials.gov Identifier: NCT00063141     History of Changes
Health Authority: United States: Food and Drug Administration

Additional relevant MeSH terms:
Digestive System Neoplasms
Molecular Mechanisms of Pharmacological Action
Antineoplastic Agents
Gastrointestinal Diseases
Colonic Diseases
Irinotecan
Cetuximab
Enzyme Inhibitors
Intestinal Diseases
Rectal Diseases
Pharmacologic Actions
Intestinal Neoplasms
Neoplasms
Neoplasms by Site
Digestive System Diseases
Therapeutic Uses
Gastrointestinal Neoplasms
Antineoplastic Agents, Phytogenic
Colorectal Neoplasms

ClinicalTrials.gov processed this record on November 30, 2009